Indole-3-carbinol (I3C), a component of
Brassica vegetables, is under study as a preventiveagent of cancers of the breast and other organs. Following ingestion, I3C is converted to a series ofoligomeric products that presumably are responsible for the in vivo effects of I3C. We report the effectsof the major trimeric product, 5,6,11,12,17,18-hexahydrocyclonona[1,2-
b:4,5-
b':7,8-
b' ']triindole (CTr),on the estrogen receptor (ER) signaling pathways. Tumor-promoting effects of high doses of I3C may bedue to activation of aryl hydrocarbon receptor (AhR)-mediated pathways; therefore, we also examinedthe effects of CTr on AhR activated processes. We observed that CTr is a strong agonist of ER function.CTr stimulated the proliferation of estrogen-responsive MCF-7 cells to a level similar to that produced byestradiol (E
2) but did not affect the growth of the estrogen-independent cell line, MDA-MD-231. CTrdisplaced E
2 in competitive-binding studies and activated ER-binding to an estrogen responsive DNAelement in gel mobility
shift assays with EC
50s of about 0.1
M. CTr activated transcription of an E
2-responsive endogenous gene and exogenous reporter genes in transfected MCF-7 cells, also with highpotency. CTr failed to activate AhR-mediated pathways, consistent with the low-binding affinity of CTrfor the AhR reported previously. Comparisons of the conformational characteristics of CTr with other ERligands indicated a remarkable similarity with tamoxifen, a selective ER antagonist used as a breast cancertherapeutic agent and suggest an excellent fit of CTr into the ligand-binding site of the ER.